Delivery Order SPE2DB24D9228-SPE2DB25FATHD
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $33,923.76 for 120-count supplies of Xtandi 40 mg capsules. The award, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, reflects a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its facility location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count packages). The contract, valued at $4,311.35, carries a firm fixed-price arrangement with an ultimate completion date of September 29, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in open federal procurement...
- The Defense Logistics Agency awarded a $267,357.79 delivery order to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) with a completion date of September 29, 2025. This firm fixed-price delivery order was issued without a set-aside designation, allowing the woman-owned small business based in Park Ridge, Illinois to compete directly in the federal pharmaceutical procurement market. The award leverages DMS Pharmaceutical Group's established capability as a...
- The U.S. Defense Logistics Agency (DLA), through the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xtandi 40 mg capsules (120 count units) valued at $4,311.35. This firm fixed-price delivery order, issued under no set-aside designation, is scheduled for completion by August 26, 2025, with fulfillment from the vendor's Park Ridge, Illinois location. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a $4.3K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120 count). The contract, issued as a firm fixed-price delivery order on September 9, 2025, with completion scheduled for September 10, 2025, represents a single pharmaceutical product delivery supporting Department of Defense healthcare operations. This award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (quantity: 120). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between the agency and the vendor. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The contract, effective August 12, 2025 with completion by August 13, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, executed on September 2, 2025, with an ultimate completion date of September 3, 2025, carries no set-aside designation. The award leverages DMS Pharmaceutical Group's existing Indefinite Delivery...